The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...

Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

LTRN READ THE FULL LTRN RESEARCH REPORT Lantern Pharma, Inc (NASDAQ:LTRN) continues to enroll its HARMONIC trial for LP-300 ...

Malayalam superstar Mammootty's team shared that the actor is on vacation for Ramzan fasting and will resume work soon. This comes after rumours of him being diagnosed with cancer started doing the ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented data at the American Association for Cancer Research (AACR) IO Annual Meeting in Los ...

Seventy-one University of Kentucky students will present their research at the National Conference on Undergraduate Research ...

In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...

From full-body MRIs to early-cancer screenings ... while 34% cited personal anecdotes. Overall, 68% of posters had a financial interest in the test they were promoting. “[Most] posts were ...

BRACELET-1 results in HR+/HER2- metastatic breast cancer surpass expectations, providing meaningful data for a registration-enabling study Data from GOBLET in pancreatic ...

DSU’s unwavering dedication to social impact is a testament to its holistic educational approach, seamlessly integrating ...

Colors of India: DSU’s B.Design Students Inspire Creativity at T ... Around 70 students from BBA and B.Com programs ...

Eastern Michigan University's Undergraduate Symposium, scheduled to take place in the Student Center on March 28, 2025, ...